Pathophysiology and treatment of fatigue in multiple sclerosis.

被引:10
|
作者
Boërio, D
Lefaucheur, JP
Hogrel, JY
Créange, A
机构
[1] Hop Henri Mondor, Serv Neurol, AP HP, F-94010 Creteil, France
[2] Hop Henri Mondor, Serv Physiol Explorat Fonct, AP HP, F-94010 Creteil, France
[3] Grp Hosp Pitie Salpetriere, Inst Mycol, F-75634 Paris, France
关键词
fatigue; evaluation; central and peripheral nervous system; immunology; treatment;
D O I
10.1016/S0035-3787(06)75017-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Patients suffering from multiple sclerosis (MS) frequently complain of fatigue (53 to 92 percent depending on studies). Fatigue can be one of the most disabling symptoms of MS and presents as physical or mental fatigue in daily living activities. Besides this permanent feeling of exhaustion, MS patients can suffer from an abnormal tiredness and lack of energy after a given motor or mental task, which defines fatigability. A number of studies explored the origins of fatigue and fatigability by means of subjective and objective tools. The implication of central nervous system dysfunctions has been established in several studies; however the contribution of peripheral nervous system factors and systemic abnormalities associated with inflammatory and immunological parameters was also suggested. The aim of this review is to present the different types of fatigue and fatigability occurring in MS patients, their origins, the investigation tools which allow the quantification of fatigue and fatigability and characterization of their mechanisms. The currently available therapeutic strategies that have been proposed to relieve this disabling symptom are presented.
引用
收藏
页码:311 / 320
页数:10
相关论文
共 50 条
  • [1] Fatigue in multiple sclerosis.
    Krupp L.B.
    Christodoulou C.
    Current Neurology and Neuroscience Reports, 2001, 1 (3) : 294 - 298
  • [2] Therapy of fatigue in multiple sclerosis. A treatment algorithm
    Veauthier, C.
    Paul, F.
    NERVENARZT, 2016, 87 (12): : 1310 - 1321
  • [3] Fatigue in multiple sclerosis - Definition, pathophysiology and treatment
    Krupp, LB
    CNS DRUGS, 2003, 17 (04) : 225 - 234
  • [4] Salvarsan treatment in multiple sclerosis.
    Schafgen, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1924, 50 : 1178 - 1178
  • [5] The malaria treatment of multiple sclerosis.
    Dreyfus, GL
    Mayer, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1930, 56 : 863 - 867
  • [6] Antimon treatment of multiple sclerosis.
    Crecelius, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1928, 54 : 1332 - 1334
  • [7] Fatigue in multiple sclerosis: pathophysiology and emergent interventions
    Ayache, S. S.
    Chalah, M. A.
    ARCHIVES ITALIENNES DE BIOLOGIE, 2018, 156 (04): : 149 - 152
  • [8] The pathophysiology of motor fatigue and fatigability in multiple sclerosis
    Patejdl, Robert
    Zettl, Uwe K.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [9] ENERGY-SAVING STRATEGIES IN THE TREATMENT OF FATIGUE IN PATIENTS WITH MULTIPLE SCLEROSIS. A PILOT STUDY
    Garcia-Burguillo, M. P.
    Aguila-Maturana, A. M.
    REVISTA DE NEUROLOGIA, 2009, 49 (04) : 181 - 185
  • [10] Autonomic nervous dysfunction and fatigue in multiple sclerosis. Is there some correlation?
    Lebre, A
    Tilbery, CP
    Mendes, MF
    MULTIPLE SCLEROSIS, 2005, 11 : S67 - S67